Articles and Insights About Wearables for Clinical Trials

Alzheimer's

VivoSense Study to Develop Digital Measures of Function for AD

 Jen Blankenship  March 16, 2023

At the a2 National Symposium: Empowering Innovation in AI/Tech + Aging, Senior Research Scientist Jen Blankenship, PhD, presented our ongoing work with the Center for Human Health and Performance at the University of Massachusetts Amherst to develop digital clinical measures that capture how patients with Alzheimer’s disease function in their real-world environments. 

Read More

VivoSense Awarded NIA/MassAITC Grant to Aid in Alzheimer's Research

 Dudley Tabakin  January 19, 2023

VivoSense, a trusted leader in the development, validation, and delivery of digital clinical measures, announced today that it has been awarded a research grant funded by the National Institute of Aging (NIA) and the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC; grant number 5P30AG073107-02 Pilot A2).

Read More

Opportunities for Real-World Measures in Alzheimer's Research

 Jen Blankenship  November 23, 2022

Alzheimer’s disease (AD) is a devastating neurodegenerative disease that progresses to impact every dimension of a patient’s life. With no cure and limited options to manage symptoms, research is underway to develop drugs that impact the most burdensome aspects of AD: memory problems and the ability to function independently.

Read More
 Newer All Articles Older 

Subscribe to Email Updates

Stay Connected

Popular